Antiproliferative and apoptotic effects of anti-human HB-EGF neutralizing polyclonal antibodies in vitro
Summary. Heparin-binding epidermal growth factor-like growth factor (HB-EGF) is a member of the epidermal growth factor family and has a variety of physiological and pathophysiological functions. Also, HB-EGF plays a pivotal role in progression of different tumors. So, HB-EGF seems to be a target mo...
Saved in:
| Date: | 2023 |
|---|---|
| Main Authors: | Siromolot, A.A., Krynina, O.I., Kolybo, D.V., Komisarenko, S.V. |
| Format: | Article |
| Language: | English |
| Published: |
PH Akademperiodyka
2023
|
| Subjects: | |
| Online Access: | https://exp-oncology.com.ua/index.php/Exp/article/view/2020-1-8 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Journal Title: | Experimental Oncology |
Institution
Experimental OncologySimilar Items
Role of the heparin-binding domain in intracellular trafficking of sHB-EGF
by: O. I. Krynina, et al.
Published: (2019)
by: O. I. Krynina, et al.
Published: (2019)
Cell model for the study of receptor and regulatory functions of human proHB-EGF
by: N. V. Korotkevych, et al.
Published: (2014)
by: N. V. Korotkevych, et al.
Published: (2014)
Obtaining and characterization of recombinant fluorescent derivatives of soluble human HB-EGF
by: N. V. Korotkevych, et al.
Published: (2014)
by: N. V. Korotkevych, et al.
Published: (2014)
Influence of human HB-EGF secreted form on cells with different EGFR and ErbB4 quantity
by: O. I. Krynina, et al.
Published: (2019)
by: O. I. Krynina, et al.
Published: (2019)
Changes in proHB-EGF expression after functional activation of the immune system cells
by: T. O. Chudina, et al.
Published: (2017)
by: T. O. Chudina, et al.
Published: (2017)
Recognition of Mycobacterium tuberculosis antigens MPT63 and MPT83 by murine polyclonal and scFv antibodies
by: A. A. Siromolot, et al.
Published: (2018)
by: A. A. Siromolot, et al.
Published: (2018)
Epitopes identification of broadly neutralizing monoclonal antibodies against Corynebacterium diphtheriae exotoxin
by: Ya. S. Kulyk, et al.
Published: (2022)
by: Ya. S. Kulyk, et al.
Published: (2022)
Prognostic role of androgen receptor expression in patients with metastatic triple negative breast cancer
by: Lyalkin, S.A., et al.
Published: (2023)
by: Lyalkin, S.A., et al.
Published: (2023)
Polyclonal antibodies against human plasminogen kringle 5
by: L. G. Kapustianenko
Published: (2017)
by: L. G. Kapustianenko
Published: (2017)
Polyclonal antibodies against human plasminogen: purification, characterization and application
by: T. A. Yatsenko, et al.
Published: (2020)
by: T. A. Yatsenko, et al.
Published: (2020)
Polyclonal antibodies against human cell-surface antigen CD34
by: Ju. S. Nikolaev, et al.
Published: (2011)
by: Ju. S. Nikolaev, et al.
Published: (2011)
Isolation and characterisation of recombinant single chain variable fragment antibodies (scFv) against human heparin-binding EGF-like growth factor
by: O. S. Oliinyk, et al.
Published: (2012)
by: O. S. Oliinyk, et al.
Published: (2012)
Evaluating the role of dithiolane rich fraction of Ferula asafoetida (apiaceae) for its antiproliferative and apoptotic properties: in vitro studies
by: Verma, S., et al.
Published: (2023)
by: Verma, S., et al.
Published: (2023)
Antiproliferative and apoptotic effect of ethanolic extract of Calocybe indica on PANC-1 and MIAPaCa2 cell lines of pancreatic cancer
by: Ghosh, S.K., et al.
Published: (2023)
by: Ghosh, S.K., et al.
Published: (2023)
Obtaining of recombinant analogue of human SHB-EGF by transposon–transposase genetic system
by: N. V. Korotkevych, et al.
Published: (2015)
by: N. V. Korotkevych, et al.
Published: (2015)
Bladder sparing surgery in high-grade bladder cancer
by: Yakovlev, P.G., et al.
Published: (2023)
by: Yakovlev, P.G., et al.
Published: (2023)
Integral characteristic of the immune system state predicts breast cancer outcome
by: Stakheyeva, M., et al.
Published: (2023)
by: Stakheyeva, M., et al.
Published: (2023)
Obtaining of recombinant human heparin binding EGF-like growth factor and perspectives of its application in biotechnology
by: N. V. Korotkevych, et al.
Published: (2010)
by: N. V. Korotkevych, et al.
Published: (2010)
Splice variants in apoptotic pathway
by: Miura, K., et al.
Published: (2012)
by: Miura, K., et al.
Published: (2012)
Evaluation of antiproliferative activity of pyrazolothiazolopyrimidine derivatives
by: N. S. Finiuk, et al.
Published: (2018)
by: N. S. Finiuk, et al.
Published: (2018)
Characterization of scFv-antibodies against diphtheria toxin, isolated from immune and naive immunoglobulin gene libraries
by: O. S. Oliinyk, et al.
Published: (2009)
by: O. S. Oliinyk, et al.
Published: (2009)
Generation and characterization of polyclonal antibodies specific to N-terminal extension of p85 isoform of ribosomal protein S6 kinase 1 (p85 S6K1)
by: L. O. Savinska, et al.
Published: (2015)
by: L. O. Savinska, et al.
Published: (2015)
Generation and characterization of polyclonal antibodies specific to N-terminal extension of p85 isoform of ribosomal protein S6 kinase 1 (p85 S6K1)
by: Savinska, L.O., et al.
Published: (2015)
by: Savinska, L.O., et al.
Published: (2015)
Incidence and long-term effects of treatment of malignant germ cell neoplasms in Ukraine
by: Fedorenko, Z.P., et al.
Published: (2023)
by: Fedorenko, Z.P., et al.
Published: (2023)
Increasing of the expression of recombinant scFv-antibodies efficiency
by: O. V. Galkin, et al.
Published: (2017)
by: O. V. Galkin, et al.
Published: (2017)
Cryoablation: Apoptotic Phase Shifting and Cryo-Sensitization
by: Dzh. Dzh. Baust
Published: (2012)
by: Dzh. Dzh. Baust
Published: (2012)
Specialized care provided to patients with rectal cancer in Kyiv city
by: Kliusov, O.M.
Published: (2023)
by: Kliusov, O.M.
Published: (2023)
Tumor microenvironment-derived miRNAs as prognostic markers of breast cancer
by: Lukianova, N.Yu., et al.
Published: (2023)
by: Lukianova, N.Yu., et al.
Published: (2023)
International scientific conference “Tumor and host: novel aspects of old problem”
Published: (2023)
Published: (2023)
Epigenetics in breast cancer
by: Atalay, C.
Published: (2013)
by: Atalay, C.
Published: (2013)
Overview on locally advanced breast cancer: defining, epidemiology, and overview on neoadjuvant therapy
by: Yalcin, B.
Published: (2013)
by: Yalcin, B.
Published: (2013)
Role of postmastectomy radiation therapy after neoadjuvant chemotherapy in locally advanced breast cancer
by: Akyurek, S., et al.
Published: (2013)
by: Akyurek, S., et al.
Published: (2013)
Management of non-inflammatory locally advanced breast cancer: focus on surgical approaches
by: Eroğlu, A., et al.
Published: (2013)
by: Eroğlu, A., et al.
Published: (2013)
Disseminated tumor cells and enhanced level of some cytokines in bone marrow and peripheral blood of breast cancer patients as predictive factors of tumor progression
by: Semesiuk, N., et al.
Published: (2013)
by: Semesiuk, N., et al.
Published: (2013)
Male breast cancer: clinical presentation, diagnosis, treatment
by: Hotko, Y.S.
Published: (2013)
by: Hotko, Y.S.
Published: (2013)
Breast reconstruction
by: Kaya, B., et al.
Published: (2013)
by: Kaya, B., et al.
Published: (2013)
A rare coincidence: facioscapulohumeral muscular dystrophy and breast cancer
by: Yazici, O., et al.
Published: (2013)
by: Yazici, O., et al.
Published: (2013)
Role of ABC-cassette transporters (MDR1, MRP1, BCRP) in the development of primary and acquired multiple drug resistance in patients with early and metastatic breast cancer
by: Kovalev, A.A., et al.
Published: (2013)
by: Kovalev, A.A., et al.
Published: (2013)
Receptor status of tumor as prognostic factor in patients with bilateral breast cancer
by: Tsyhyka, D.Y., et al.
Published: (2013)
by: Tsyhyka, D.Y., et al.
Published: (2013)
Staging, risk assessment and screening of breast cancer
by: Yalcin, B.
Published: (2013)
by: Yalcin, B.
Published: (2013)
Similar Items
-
Role of the heparin-binding domain in intracellular trafficking of sHB-EGF
by: O. I. Krynina, et al.
Published: (2019) -
Cell model for the study of receptor and regulatory functions of human proHB-EGF
by: N. V. Korotkevych, et al.
Published: (2014) -
Obtaining and characterization of recombinant fluorescent derivatives of soluble human HB-EGF
by: N. V. Korotkevych, et al.
Published: (2014) -
Influence of human HB-EGF secreted form on cells with different EGFR and ErbB4 quantity
by: O. I. Krynina, et al.
Published: (2019) -
Changes in proHB-EGF expression after functional activation of the immune system cells
by: T. O. Chudina, et al.
Published: (2017)